| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.075 | 0.04 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.1 | 0.04 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.09 | 0.04 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.094 | 0.04 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.062 | 0.04 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.04 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.04 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.1 | 0.04 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | 0.34 | 0.04 |